Portal do Butantan

CoronaVac is used in 45 countries: understand the distribution of the vaccine that represents 25% of all immunizers against Covid-19


Publicado em: 01/01/1970

"CoronaVac, a vaccine from Butantan and the Chinese pharmaceutical Sinovac against SARS-CoV-2, has been used in 45 countries on almost every continent since the beginning of the Covid-19 pandemic. With more than 7.9 billion doses of immunizing agents already administered, CoronaVac represents 25% of the world production of immunizing agents, accounting for 2 billion doses.

Brazil started its vaccination campaign on 1/1, with CoronaVac. Until September, Butantan delivered 100 million doses of the vaccine to the Ministry of Health to help fight the Covid-19 pandemic, caused by the SARS-CoV-2 virus.

 

Latin America

The immunizing agent is one of the most used in vaccination campaigns against Covid-19 in Latin American countries. (See the list of countries that adopt the immunizing agent at the end of the article)

In Chile, 73.32% of doses applied in the country until November were from CoronaVac, according to Our World in Data, a digital scientific data platform that gathers, among other things, world data on Covid-19. Chile immunized 84.2% of the population with both doses, equivalent to 16 million people. Currently, the Andean country has been using the vaccine from Butantan and Sinovac to immunize people from six years of age.

In Uruguay, 60% of the administered doses are CoronaVac, according to November data from Our World in Data. The country has already vaccinated about 2.65 million people (76.4% of the population) with the two doses.

In Ecuador, the majority of doses (56.86%) of the 24.1 million applied were of CoronaVac as of November 21, according to Our World in Data.

In March, Paraguay received a donation of 20,000 doses of CoronaVac from Chile to be able to begin vaccination in the country of 7 million people. In October, the country's Ministry of Health announced that it would receive another 30,000 doses of Conmebol.

Mexico, with more than 64.9 million people fully vaccinated, applied 20 million doses of CoronaVac until November, according to the local Ministry of Health.

In June, the Dominican Republic received 7.8 million doses of CoronaVac.

 

Europe

In March, Ukraine granted approval for the use of CoronaVac, and as of November, of the 24 million Covid-19 vaccines administered in the country, 7.66 million were CoronaVac, according to Our World in Data.

Also in March, Albania launched its vaccination campaign using mostly doses of CoronaVac, securing Turkey's first batch of 1 million doses. Turkey also donated 300,000 doses of the immunizer to Bosnia in the period. In April, Moldova purchased 400,000 doses of CoronaVac.

In June, Northern Cyprus received 190,000 doses donated by Turkey and Northern Macedonia another 30,000 doses donated by the same country.

 

Asia

China took the lead and authorized the emergency use of CoronaVac in August 2020 and its definitive use in February. In June, the country authorized the emergency use of CoronaVac in children and adolescents aged three to 17 years. Until November, 74.5% of its population had already been vaccinated with the two doses, according to Our World in Data. The country has donated the immunizing agent to several countries on the continent.

In Myanmar, CoronaVac has been in use since August 8. In November, the country received 2 million doses of CoronaVac, half of them donated by the Chinese giant. In October, it received a batch of over 2 million through the COVAX Facility, a consortium of the World Health Organization (WHO) that aims to supply vaccines to developing countries (Sinovac signed agreements to supply a total of 380 million doses to the COVAX Facility until the first half of 2022).

In Malaysia, 37.6% of the 53 million doses given until the end of November were CoronaVac, according to the local Ministry of Health. CoronaVac was approved for emergency use in March in the country.

The Philippines purchased 50 million doses of CoronaVac to vaccinate its population, in addition to donating 2 million doses from China, making the immunizer the most used in the country until November, according to the local government.

In October, Singapore added CoronaVac to its National Vaccination Program for people aged 18 and over who are ineligible for mRNA vaccines due to allergies or serious adverse reactions after the first dose.

In Hong Kong, 36.83% of the 9.4 million doses administered in the territory were from CoronaVac through November, according to Our World in Data. In the same month, the country approved the use of CoronaVac in children from the age of three.

Indonesia signed agreements to purchase 140 million doses of CoronaVac as early as December 2020. The country approved the emergency use authorization on 1/11, and by June the country had received 118.7 million doses of CoronaVac. In the same month, Indonesia authorized the use of the immunizing agent for children under 12 years of age.

In February, Cambodia approved CoronaVac for emergency use and received 10.5 million doses. In the same month, Thailand approved emergency use and began its vaccination program, receiving 10 million doses up to July, according to the local government.

In March, Kazakhstan ordered 3 million doses of CoronaVac, of which 500,000 arrived in June and were approved for use by the Ministry of Health. In April, Pakistan granted an emergency use authorization for CoronaVac and received 14.5 million doses in July. 

 

Middle East and Caucasus countries

The most recent acquisitions in the Middle East involve Saudi Arabia, which in October signed an agreement to distribute CoronaVac to 7,000 healthcare professionals after conducting phase 3 clinical trials with the country's National Guard.

Turkey approved the emergency use of CoronaVac on 1/1, and in February the country signed an agreement for a total of 100 million doses. A phase 3 study, carried out with more than 10,000 people, showed the high efficacy of CoronaVac, in research published in the scientific journal The Lancet.

The Azerbaijani government has purchased 9 million doses of CoronaVac from Turkey and China to launch the anti-Covid vaccination campaign for its population of just over 10 million.

In May, Armenia received 100,000 doses of CoronaVac from China, the same month Georgia began CoronaVac vaccination with 1 million doses received in July.

 

Africa

In March, Zimbabwe approved the emergency use of CoronaVac and 1 million doses arrived in the country. In the same month, the Tunisian Ministry of Health received 200,000 doses.

Benin received 203,000 doses of CoronaVac and started vaccinating on March 29, prioritizing health professionals, people over 60 and with comorbidities. Also in March, Djibouti received 300,000 doses of CoronaVac.

In April, Botswana received 200,000 doses of vaccine as a donation and purchased an additional 200,000 doses to be used in the vaccination program.

In April, Guinea received 300,000 purchased doses of CoronaVac; Somalia received 200,000 doses; Togo another 200,000; and Libya received 150,000 doses from Turkey. Also in April, Egypt approved the emergency use of CoronaVac in the country. 

 

Countries that administer CoronaVac to their populations

August (2020)

China

December (2020)

Turkey

January (2021)

Azerbaijan

Brazil

Chile

Indonesia

February (2021)

Botswana

Cambodia

China

Ecuador

Hong Kong

Laos

Dominican Republic

Thailand

March (2021)

Albania

Colombia

El Salvador

Malaysia

Mexico

Paraguay

Ukraine

Uruguay

Zimbabwe

April (2021)

Philippines

Pakistan

May (2021)

Armenia

Georgia

Tunisia

June (2021)

Bangladesh

Kazakhstan

Nepal

East Timor

July (2021)

Tanzania

October (2021)

Saudi Arabia

Singapore

 

Countries that received CoronaVac donations (from China or Turkey)

March (2021)

Benin

Djibouti

April (2021)

Libya

June (2021)

Bosnia Herzegovina

Macedonia

Tajikistan

Togo

 

Countries that received CoronaVac donations (through the COVAX Facility)

August (2021)

Algeria

September (2021)

Venezuela

November (2021)

Myanmar